These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9439900)

  • 41. Isoniazid hepatotoxicity after orthotopic liver transplantation.
    Schluger LK; Sheiner PA; Jonas M; Guarrera JV; Fiel IM; Meyers B; Berk PD
    Mt Sinai J Med; 1996; 63(5-6):364-9. PubMed ID: 8898542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of long-term isoniazid preventive therapy in children with HIV: a comparison of two dosing schedules.
    le Roux SM; Cotton MF; Myer L; le Roux DM; Schaaf HS; Lombard CJ; Zar HJ
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):26-31. PubMed ID: 23146410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for isoniazid hepatotoxicity in children with latent TB and TB: difference from adults.
    Devrim I; Olukman O; Can D; Dizdarer C
    Chest; 2010 Mar; 137(3):737-8. PubMed ID: 20202962
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical and pathological analysis of liver injury resulting from rifampin and isoniazid].
    Xing T; Chen J; Zhang G
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Feb; 20(1):33-5. PubMed ID: 10072800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful living donor liver transplantation of fulminant liver failure due to isoniazid prophylaxis.
    Çakır T; Ara C; Soyer HV; Koc S
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26106175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The uses of error: iatrogenic hepatitis.
    Rodés J; Bruguera M
    Lancet; 2001 Mar; 357(9258):791. PubMed ID: 11253985
    [No Abstract]   [Full Text] [Related]  

  • 47. Isoniazid-related fatal hepatitis.
    Millard PS; Wilcosky TC; Reade-Christopher SJ; Weber DJ
    West J Med; 1996 Jun; 164(6):486-91. PubMed ID: 8764622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Simkins J; Abbo LM; Camargo JF; Rosa R; Morris MI
    Transplantation; 2017 Jun; 101(6):1468-1472. PubMed ID: 27548035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of latent tuberculosis infection: An update.
    Lobue P; Menzies D
    Respirology; 2010 May; 15(4):603-22. PubMed ID: 20409026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antitubercular drug-induced liver injuries].
    Guo Y; Cui D
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960
    [No Abstract]   [Full Text] [Related]  

  • 51. [Liver damage in treatment of latent tuberculous infection by isoniazid].
    Ito K; Hoshino H; Nakazono T; Masuyama H; Sugita H; Yoshiyama T; Kato S
    Kekkaku; 2006 Nov; 81(11):651-60. PubMed ID: 17154043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perspective: preventive isoniazid therapy and the liver.
    Israel HL; Gottlieb JE; Maddrey WC
    Chest; 1992 May; 101(5):1298-301. PubMed ID: 1582287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for hepatotoxicity during anti-tuberculosis chemotherapy in Asian populations.
    Yew WW
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):99-100. PubMed ID: 11263525
    [No Abstract]   [Full Text] [Related]  

  • 54. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
    Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
    Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Management of adverse effects with antituberculosis chemotherapy].
    Tsuyuguchi K; Wada M
    Kekkaku; 2011 Feb; 86(2):87-99. PubMed ID: 21404653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metallothionein protects against isoniazid-induced liver injury through the inhibition of CYP2E1-dependent oxidative and nitrosative impairment in mice.
    Lian Y; Zhao J; Wang YM; Zhao J; Peng SQ
    Food Chem Toxicol; 2017 Apr; 102():32-38. PubMed ID: 28126494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isoniazid-associated hepatitis in a Melanesian.
    Britton WJ
    P N G Med J; 1977 Dec; 20(4):198-202. PubMed ID: 277000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure.
    Metushi IG; Sanders C; ; Lee WM; Uetrecht J
    Hepatology; 2014 Mar; 59(3):1084-93. PubMed ID: 23775837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Liver damage from tuberculosis treatment].
    Keiner F
    Med Klin; 1981 Jun; 76(13):376-7. PubMed ID: 7254121
    [No Abstract]   [Full Text] [Related]  

  • 60. [Severe hepatitis induced by chemotherapy with antitubercular agents in childhood. 2 cases].
    Chapoy P; Ferracci JP; Mattei JF; Granjon B; Louchet E
    Pediatrie; 1978; 3(7):637-45. PubMed ID: 740454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.